Somatic Disease Among Alcohol Abusers in an Out-day Patients' Clinic
|ClinicalTrials.gov Identifier: NCT01081197|
Recruitment Status : Completed
First Posted : March 5, 2010
Last Update Posted : May 3, 2013
Alcohol abuse is associated with a variety of clinical diseases, but studies on prevalence of different somatic diseases among alcohol abusers are lacking. Studies on populations in an out-day patients' clinic are also lacking.
The investigators aim to study somatic health standard in an out-day patients' clinic population of alcohol abusers, with regard to prevalence of different kinds of somatic diseases, and how the interaction of somatic and psychiatric treatment can influence on patients quality of life. Clinical examination including blood samples and echocardiographic examinations in all participants, other additional examinations (as x-ray, CT or MRI if indicated by clinical findings).
|Condition or disease||Intervention/treatment|
|HEART DISEASE Liver Failure DEPRESSIVE DISORDER Alcoholic Neuropathy||Other: Psychiatric and somatic examinations and ,if clinical indicated, treatment|
|Study Type :||Observational|
|Actual Enrollment :||150 participants|
|Official Title:||Somatic Disease Among Alcohol Abusers in an Out-day Patients' Clinic. A Neglected Area|
|Study Start Date :||March 2010|
|Actual Primary Completion Date :||December 2012|
|Actual Study Completion Date :||May 2013|
Out-day patients' clinic
Alcohol abusers referred to out-day patients' clinic which consent to participate in the study
Other: Psychiatric and somatic examinations and ,if clinical indicated, treatment
Patients referred to the clinic will be given optimal treatment for revealed psychiatric and/or somatic disease including conversational therapy, and if indicated therapeutic interventions with respect to any kind of disease.
Control group for the cardiac arm of the study will be matched controls from the Nord-Trøndelag Health Study (HUNT)
- Prevalence of different kinds of somatic disease [ Time Frame: 3 months after inclusion ]Prevalence of somatic disease at study attendance of any kind, specified for heart disease, gall- and liver disease, neuropathic disease.
- Prevalence of former somatic disease [ Time Frame: 3 months after inclusion ]Prevalence of former somatic disease investigated by anamnestic examination, search in patient journals and communication with the patients community health service.
- Outcome of psychiatric and somatic treatment of alcohol abusers [ Time Frame: 1 year after stopped inclusion ]Quality of life and score of somatic and psychiatric health 1 year after inclusion
Biospecimen Retention: Samples Without DNA
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01081197
|Levanger Hospital, Dep. of Psychiatry|
|Levanger, Norway, N-7600|
|Principal Investigator:||Erling Dalen, MD||Levanger Hospital|